 | • レポートコード：QYR2104Z2190 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、遺伝子改変T細胞のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍浸潤リンパ球、T細胞受容体{TCR}、キメラ抗原受容体（CAR））、用途別市場規模（病院、がん研究センター、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・遺伝子改変T細胞の市場動向 ・企業の競争状況、市場シェア ・遺伝子改変T細胞の種類別市場規模（腫瘍浸潤リンパ球、T細胞受容体{TCR}、キメラ抗原受容体（CAR）） ・遺伝子改変T細胞の用途別市場規模（病院、がん研究センター、クリニック） ・遺伝子改変T細胞の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝子改変T細胞のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝子改変T細胞のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝子改変T細胞の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝子改変T細胞の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Autolus Limited、Bellicum Pharmaceuticals、Cells Medica、Elli Lilly and Company、Gilead Sciences、Juno Therapeutics、Novartis、Oxford Biomedica、Pfizer、Precision Bioscience、Redmile Group、Seeking Alpha、Unum Therapeutics） ・結論 |
Market Analysis and Insights: Global Engineered T Cells Market
The global Engineered T Cells market size is projected to reach US$ 1368.4 million by 2026, from US$ 263.2 million in 2019, at a CAGR of 26.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Engineered T Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Engineered T Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Engineered T Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Engineered T Cells market.
Global Engineered T Cells Scope and Market Size
Engineered T Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Engineered T Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
Segment by Application
Hospitals
Cancer Research Centers
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Elli Lilly and Company
Gilead Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Engineered T Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tumor Infiltrating Lymphocytes
1.2.3 T Cell Receptor {TCR}
1.2.4 Chimeric Antigen Receptor (CAR)
1.3 Market by Application
1.3.1 Global Engineered T Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Engineered T Cells Market Perspective (2016-2027)
2.2 Engineered T Cells Growth Trends by Regions
2.2.1 Engineered T Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Engineered T Cells Historic Market Share by Regions (2016-2021)
2.2.3 Engineered T Cells Forecasted Market Size by Regions (2022-2027)
2.3 Engineered T Cells Industry Dynamic
2.3.1 Engineered T Cells Market Trends
2.3.2 Engineered T Cells Market Drivers
2.3.3 Engineered T Cells Market Challenges
2.3.4 Engineered T Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Engineered T Cells Players by Revenue
3.1.1 Global Top Engineered T Cells Players by Revenue (2016-2021)
3.1.2 Global Engineered T Cells Revenue Market Share by Players (2016-2021)
3.2 Global Engineered T Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Engineered T Cells Revenue
3.4 Global Engineered T Cells Market Concentration Ratio
3.4.1 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Engineered T Cells Revenue in 2020
3.5 Engineered T Cells Key Players Head office and Area Served
3.6 Key Players Engineered T Cells Product Solution and Service
3.7 Date of Enter into Engineered T Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Engineered T Cells Breakdown Data by Type
4.1 Global Engineered T Cells Historic Market Size by Type (2016-2021)
4.2 Global Engineered T Cells Forecasted Market Size by Type (2022-2027)
5 Engineered T Cells Breakdown Data by Application
5.1 Global Engineered T Cells Historic Market Size by Application (2016-2021)
5.2 Global Engineered T Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Engineered T Cells Market Size (2016-2027)
6.2 North America Engineered T Cells Market Size by Type
6.2.1 North America Engineered T Cells Market Size by Type (2016-2021)
6.2.2 North America Engineered T Cells Market Size by Type (2022-2027)
6.2.3 North America Engineered T Cells Market Size by Type (2016-2027)
6.3 North America Engineered T Cells Market Size by Application
6.3.1 North America Engineered T Cells Market Size by Application (2016-2021)
6.3.2 North America Engineered T Cells Market Size by Application (2022-2027)
6.3.3 North America Engineered T Cells Market Size by Application (2016-2027)
6.4 North America Engineered T Cells Market Size by Country
6.4.1 North America Engineered T Cells Market Size by Country (2016-2021)
6.4.2 North America Engineered T Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Engineered T Cells Market Size (2016-2027)
7.2 Europe Engineered T Cells Market Size by Type
7.2.1 Europe Engineered T Cells Market Size by Type (2016-2021)
7.2.2 Europe Engineered T Cells Market Size by Type (2022-2027)
7.2.3 Europe Engineered T Cells Market Size by Type (2016-2027)
7.3 Europe Engineered T Cells Market Size by Application
7.3.1 Europe Engineered T Cells Market Size by Application (2016-2021)
7.3.2 Europe Engineered T Cells Market Size by Application (2022-2027)
7.3.3 Europe Engineered T Cells Market Size by Application (2016-2027)
7.4 Europe Engineered T Cells Market Size by Country
7.4.1 Europe Engineered T Cells Market Size by Country (2016-2021)
7.4.2 Europe Engineered T Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Engineered T Cells Market Size (2016-2027)
8.2 Asia-Pacific Engineered T Cells Market Size by Type
8.2.1 Asia-Pacific Engineered T Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Engineered T Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Engineered T Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Engineered T Cells Market Size by Application
8.3.1 Asia-Pacific Engineered T Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Engineered T Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Engineered T Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Engineered T Cells Market Size by Region
8.4.1 Asia-Pacific Engineered T Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Engineered T Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Engineered T Cells Market Size (2016-2027)
9.2 Latin America Engineered T Cells Market Size by Type
9.2.1 Latin America Engineered T Cells Market Size by Type (2016-2021)
9.2.2 Latin America Engineered T Cells Market Size by Type (2022-2027)
9.2.3 Latin America Engineered T Cells Market Size by Type (2016-2027)
9.3 Latin America Engineered T Cells Market Size by Application
9.3.1 Latin America Engineered T Cells Market Size by Application (2016-2021)
9.3.2 Latin America Engineered T Cells Market Size by Application (2022-2027)
9.3.3 Latin America Engineered T Cells Market Size by Application (2016-2027)
9.4 Latin America Engineered T Cells Market Size by Country
9.4.1 Latin America Engineered T Cells Market Size by Country (2016-2021)
9.4.2 Latin America Engineered T Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Engineered T Cells Market Size (2016-2027)
10.2 Middle East & Africa Engineered T Cells Market Size by Type
10.2.1 Middle East & Africa Engineered T Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Engineered T Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Engineered T Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Engineered T Cells Market Size by Application
10.3.1 Middle East & Africa Engineered T Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Engineered T Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Engineered T Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Engineered T Cells Market Size by Country
10.4.1 Middle East & Africa Engineered T Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Engineered T Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Autolus Limited
11.1.1 Autolus Limited Company Details
11.1.2 Autolus Limited Business Overview
11.1.3 Autolus Limited Engineered T Cells Introduction
11.1.4 Autolus Limited Revenue in Engineered T Cells Business (2016-2021)
11.1.5 Autolus Limited Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Details
11.2.2 Bellicum Pharmaceuticals Business Overview
11.2.3 Bellicum Pharmaceuticals Engineered T Cells Introduction
11.2.4 Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2016-2021)
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Cells Medica
11.3.1 Cells Medica Company Details
11.3.2 Cells Medica Business Overview
11.3.3 Cells Medica Engineered T Cells Introduction
11.3.4 Cells Medica Revenue in Engineered T Cells Business (2016-2021)
11.3.5 Cells Medica Recent Development
11.4 Elli Lilly and Company
11.4.1 Elli Lilly and Company Company Details
11.4.2 Elli Lilly and Company Business Overview
11.4.3 Elli Lilly and Company Engineered T Cells Introduction
11.4.4 Elli Lilly and Company Revenue in Engineered T Cells Business (2016-2021)
11.4.5 Elli Lilly and Company Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Engineered T Cells Introduction
11.5.4 Gilead Sciences Revenue in Engineered T Cells Business (2016-2021)
11.5.5 Gilead Sciences Recent Development
11.6 Juno Therapeutics
11.6.1 Juno Therapeutics Company Details
11.6.2 Juno Therapeutics Business Overview
11.6.3 Juno Therapeutics Engineered T Cells Introduction
11.6.4 Juno Therapeutics Revenue in Engineered T Cells Business (2016-2021)
11.6.5 Juno Therapeutics Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Engineered T Cells Introduction
11.7.4 Novartis Revenue in Engineered T Cells Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Oxford Biomedica
11.8.1 Oxford Biomedica Company Details
11.8.2 Oxford Biomedica Business Overview
11.8.3 Oxford Biomedica Engineered T Cells Introduction
11.8.4 Oxford Biomedica Revenue in Engineered T Cells Business (2016-2021)
11.8.5 Oxford Biomedica Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Engineered T Cells Introduction
11.9.4 Pfizer Revenue in Engineered T Cells Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Precision Bioscience
11.10.1 Precision Bioscience Company Details
11.10.2 Precision Bioscience Business Overview
11.10.3 Precision Bioscience Engineered T Cells Introduction
11.10.4 Precision Bioscience Revenue in Engineered T Cells Business (2016-2021)
11.10.5 Precision Bioscience Recent Development
11.11 Redmile Group
11.11.1 Redmile Group Company Details
11.11.2 Redmile Group Business Overview
11.11.3 Redmile Group Engineered T Cells Introduction
11.11.4 Redmile Group Revenue in Engineered T Cells Business (2016-2021)
11.11.5 Redmile Group Recent Development
11.12 Seeking Alpha
11.12.1 Seeking Alpha Company Details
11.12.2 Seeking Alpha Business Overview
11.12.3 Seeking Alpha Engineered T Cells Introduction
11.12.4 Seeking Alpha Revenue in Engineered T Cells Business (2016-2021)
11.12.5 Seeking Alpha Recent Development
11.13 Unum Therapeutics
11.13.1 Unum Therapeutics Company Details
11.13.2 Unum Therapeutics Business Overview
11.13.3 Unum Therapeutics Engineered T Cells Introduction
11.13.4 Unum Therapeutics Revenue in Engineered T Cells Business (2016-2021)
11.13.5 Unum Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Engineered T Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tumor Infiltrating Lymphocytes
Table 3. Key Players of T Cell Receptor {TCR}
Table 4. Key Players of Chimeric Antigen Receptor (CAR)
Table 5. Global Engineered T Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Engineered T Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Engineered T Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Engineered T Cells Market Share by Regions (2016-2021)
Table 9. Global Engineered T Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Engineered T Cells Market Share by Regions (2022-2027)
Table 11. Engineered T Cells Market Trends
Table 12. Engineered T Cells Market Drivers
Table 13. Engineered T Cells Market Challenges
Table 14. Engineered T Cells Market Restraints
Table 15. Global Engineered T Cells Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Engineered T Cells Market Share by Players (2016-2021)
Table 17. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Engineered T Cells as of 2020)
Table 18. Ranking of Global Top Engineered T Cells Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Engineered T Cells Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Engineered T Cells Product Solution and Service
Table 22. Date of Enter into Engineered T Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Engineered T Cells Revenue Market Share by Type (2016-2021)
Table 26. Global Engineered T Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Engineered T Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Engineered T Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Engineered T Cells Revenue Market Share by Application (2016-2021)
Table 30. Global Engineered T Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Engineered T Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Engineered T Cells Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Engineered T Cells Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Engineered T Cells Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Engineered T Cells Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Engineered T Cells Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Engineered T Cells Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Engineered T Cells Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Engineered T Cells Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Engineered T Cells Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Engineered T Cells Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Engineered T Cells Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Engineered T Cells Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Engineered T Cells Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Engineered T Cells Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Engineered T Cells Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Engineered T Cells Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Engineered T Cells Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Engineered T Cells Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Engineered T Cells Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Engineered T Cells Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Engineered T Cells Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Engineered T Cells Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Engineered T Cells Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Engineered T Cells Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Engineered T Cells Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Engineered T Cells Market Size by Country (2022-2027) & (US$ Million)
Table 62. Autolus Limited Company Details
Table 63. Autolus Limited Business Overview
Table 64. Autolus Limited Engineered T Cells Product
Table 65. Autolus Limited Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 66. Autolus Limited Recent Development
Table 67. Bellicum Pharmaceuticals Company Details
Table 68. Bellicum Pharmaceuticals Business Overview
Table 69. Bellicum Pharmaceuticals Engineered T Cells Product
Table 70. Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 71. Bellicum Pharmaceuticals Recent Development
Table 72. Cells Medica Company Details
Table 73. Cells Medica Business Overview
Table 74. Cells Medica Engineered T Cells Product
Table 75. Cells Medica Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 76. Cells Medica Recent Development
Table 77. Elli Lilly and Company Company Details
Table 78. Elli Lilly and Company Business Overview
Table 79. Elli Lilly and Company Engineered T Cells Product
Table 80. Elli Lilly and Company Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 81. Elli Lilly and Company Recent Development
Table 82. Gilead Sciences Company Details
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Engineered T Cells Product
Table 85. Gilead Sciences Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 86. Gilead Sciences Recent Development
Table 87. Juno Therapeutics Company Details
Table 88. Juno Therapeutics Business Overview
Table 89. Juno Therapeutics Engineered T Cells Product
Table 90. Juno Therapeutics Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 91. Juno Therapeutics Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Engineered T Cells Product
Table 95. Novartis Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Oxford Biomedica Company Details
Table 98. Oxford Biomedica Business Overview
Table 99. Oxford Biomedica Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 100. Oxford Biomedica Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Engineered T Cells Product
Table 104. Pfizer Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Precision Bioscience Company Details
Table 107. Precision Bioscience Business Overview
Table 108. Precision Bioscience Engineered T Cells Product
Table 109. Precision Bioscience Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 110. Precision Bioscience Recent Development
Table 111. Redmile Group Company Details
Table 112. Redmile Group Business Overview
Table 113. Redmile Group Engineered T Cells Product
Table 114. Redmile Group Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 115. Redmile Group Recent Development
Table 116. Seeking Alpha Company Details
Table 117. Seeking Alpha Business Overview
Table 118. Seeking Alpha Engineered T Cells Product
Table 119. Seeking Alpha Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 120. Seeking Alpha Recent Development
Table 121. Unum Therapeutics Company Details
Table 122. Unum Therapeutics Business Overview
Table 123. Unum Therapeutics Engineered T Cells Product
Table 124. Unum Therapeutics Revenue in Engineered T Cells Business (2016-2021) & (US$ Million)
Table 125. Unum Therapeutics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Engineered T Cells Market Share by Type: 2020 VS 2027
Figure 2. Tumor Infiltrating Lymphocytes Features
Figure 3. T Cell Receptor {TCR} Features
Figure 4. Chimeric Antigen Receptor (CAR) Features
Figure 5. Global Engineered T Cells Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Clinics Case Studies
Figure 9. Engineered T Cells Report Years Considered
Figure 10. Global Engineered T Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Engineered T Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Engineered T Cells Market Share by Regions: 2020 VS 2027
Figure 13. Global Engineered T Cells Market Share by Regions (2022-2027)
Figure 14. Global Engineered T Cells Market Share by Players in 2020
Figure 15. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Engineered T Cells as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Engineered T Cells Revenue in 2020
Figure 17. Global Engineered T Cells Revenue Market Share by Type (2016-2021)
Figure 18. Global Engineered T Cells Revenue Market Share by Type (2022-2027)
Figure 19. North America Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Engineered T Cells Market Share by Type (2016-2027)
Figure 21. North America Engineered T Cells Market Share by Application (2016-2027)
Figure 22. North America Engineered T Cells Market Share by Country (2016-2027)
Figure 23. United States Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Engineered T Cells Market Share by Type (2016-2027)
Figure 27. Europe Engineered T Cells Market Share by Application (2016-2027)
Figure 28. Europe Engineered T Cells Market Share by Country (2016-2027)
Figure 29. Germany Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Engineered T Cells Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Engineered T Cells Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Engineered T Cells Market Share by Region (2016-2027)
Figure 39. China Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Engineered T Cells Market Share by Type (2016-2027)
Figure 47. Latin America Engineered T Cells Market Share by Application (2016-2027)
Figure 48. Latin America Engineered T Cells Market Share by Country (2016-2027)
Figure 49. Mexico Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Engineered T Cells Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Engineered T Cells Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Engineered T Cells Market Share by Country (2016-2027)
Figure 55. Turkey Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Engineered T Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Autolus Limited Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 59. Bellicum Pharmaceuticals Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 60. Cells Medica Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 61. Elli Lilly and Company Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 62. Gilead Sciences Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 63. Juno Therapeutics Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 65. Oxford Biomedica Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 67. Precision Bioscience Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 68. Redmile Group Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 69. Seeking Alpha Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 70. Unum Therapeutics Revenue Growth Rate in Engineered T Cells Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の遺伝子改変T細胞市場 2021：企業別、地域別、種類・用途別 The Engineered T Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation. Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasi…